The NNHLA has quality improvement at its centre. Starting with the NNHLA Quality Improvement goals, which were developed following a thorough scoping exercise in 2023 and in consultation with stakeholders in the Clinical Reference Group (CRG). These are as follows:
- Improving timely diagnosis and treatment
- Treatment appropriate to the subtype of NHL
- Improving safety and reducing toxicity of NHL therapy
- Improving overall survival
- Reducing variation in NHL management among NHS providers.
Accompanying these. the NNHLA has identified eleven performance indicators, which are mapped to these five quality improvement goals and clinical guidelines.
The Quality Improvement Plan describes the approach taken across the NATCAN cancer audits to develop improvement goals and performance indicators, ensuring these are measurable, actionable and improvable. (Also see Metrics Form, link above).
Implementing a Quality Improvement intervention, has been the latest work to be delivered by the NNHLA team in this area (See Quality Improvement intervention, link above).